Lexicon Pharmaceuticals (LXRX) Change in Cash: 2009-2024
Historic Change in Cash for Lexicon Pharmaceuticals (LXRX) over the last 16 years, with Dec 2024 value amounting to $44.2 million.
- Lexicon Pharmaceuticals' Change in Cash fell 93.80% to $9.7 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$155.9 million, marking a year-over-year decrease of 212.07%. This contributed to the annual value of $44.2 million for FY2024, which is 285.05% up from last year.
- As of FY2024, Lexicon Pharmaceuticals' Change in Cash stood at $44.2 million, which was up 285.05% from -$23.9 million recorded in FY2023.
- Lexicon Pharmaceuticals' Change in Cash's 5-year high stood at $90.2 million during FY2020, with a 5-year trough of -$62.2 million in FY2021.
- Moreover, its 3-year median value for Change in Cash was -$17.7 million (2022), whereas its average is $863,667.
- Per our database at Business Quant, Lexicon Pharmaceuticals' Change in Cash spiked by 303.62% in 2020 and then crashed by 168.99% in 2021.
- Over the past 5 years, Lexicon Pharmaceuticals' Change in Cash (Yearly) stood at $90.2 million in 2020, then crashed by 168.99% to -$62.2 million in 2021, then skyrocketed by 71.51% to -$17.7 million in 2022, then tumbled by 34.76% to -$23.9 million in 2023, then skyrocketed by 285.05% to $44.2 million in 2024.